Dachaigh › Galar Depressive Mòr › New York › New York City
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an New York City, NY
Tha 36 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann agus timcheall air New York City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
A’ fastadhÌre 3
- Adams Clinical Harlem, New York
- New York State Psychiatric Institute, New York
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
A’ fastadhÌre 3
- Adams Clinical Harlem, New York
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
A’ fastadhÌre 3
- Fieve Clinical Research Inc, New York
- Adams Clinical Harlem, New York
- Manhattan Behavioral Medicine, New York
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
A’ fastadhÌre 3
- Manhattan Behavioral Medicine, New York
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
A’ fastadhÌre 3
- Fieve Clinical Research Inc, New York
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
A’ fastadhÌre 2
- Ima Clinical Research - Nyc Midtown, New York
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
A’ fastadhÌre 3
- Vanda Investigational Site, New York
- Vanda Investigational Site, New York
DBS for TRD With the Medtronic Percept PC
A’ fastadh
- Icahn School of Medicine at Mount Sinai, Mount Sinai West, New York
Pattern Separation in Major Depressive Disorder
A’ fastadhÌre 1
- New York State Psychiatric Institute (NYSPI), New York
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
A’ fastadhÌre 2
- Seaport Investigator Site, New York
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
A’ fastadhÌre 3
- Fieve Clinical Research, Inc., New York
- IMA Clinical Research, New York
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
A’ fastadhÌre 2
- Draig Clinical Site, New York
- Draig Clinical Site, New York
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
A’ fastadh
- Mount Sinai Hospital, New York
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
A’ fastadhÌre 2
- Draig Clinical Site, New York
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A’ fastadhÌre 3
- Neurocrine Clinical Site, New York
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A’ fastadhÌre 3
- Neurocrine Clinical Site, New York
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
A’ fastadhÌre 2
- IMA Clinical Research - NYC Midtown, New York
- IMA Clinical Research - NYC Uptown, New York
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
A’ fastadhÌre 3
- Clinical Research Site, New York
- Clinical Research Site, New York
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
A’ fastadhÌre 3
- Neurocrine Clinical Site, New York
- Neurocrine Clinical Site, New York
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
A’ fastadh
- NYU Langone Health, New York
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
A’ fastadhÌre 2
- Ima Clinical Research - Manhattan /ID# 278212, New York
- Manhattan Behavioral Medicine /ID# 277910, New York
tDCS: Sleep to Mood in Depression (S2M-D)
A’ fastadh
- NYU Langone Health, New York
Triage Survey for Psychiatry Research Eligibility
A’ fastadhSgrùdadh amharc
- Adams Clinical, Harlem, New York
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
A’ fastadhÌre 2
- The Medical Research Network, LLC, New York
Aβ Dynamics in LLMD
A’ fastadhÌre 4
- NYU Langone Health, New York
Maintenance rTMS for Depression (Maitr-De)
A’ fastadh
- Weill Cornell Medicine, New York
Neutralizing Interleukin (IL)-6
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
- Icahn School of Medicine at Mount Sinai, New York
Mindfulness-Based fMRI Neurofeedback for Depression
A’ fastadh
- Columbia University Irving Medical Center, New York
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality
A’ fastadh
- Weill Cornell Medicine, New York
Biomarker-guided rTMS for Treatment Resistant Depression
A’ fastadhÌre 3
- Weill Cornell Medicine, New York
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
A’ fastadh
- NYU Langone Health, New York
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients
A’ fastadh
- Icahn School of Medicine at Mount Sinai, New York
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
A’ fastadhÌre 2
- Icahn School of Medicine at Mount Sinai, New York
Neural Circuit Effects of Ketamine in Depression
A’ fastadhÌre 4Fàilte do shaor-thoilich fhallain
- Icahn School of Medicine at Mount Sinai, New York
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
A’ fastadhÌre 2
- Icahn School of Medicine at Mount Sinai, Center for Psychedelic Therapy Research, New York
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
A’ fastadhÌre 4
- Clinical Research Site, New York
Sgrùdaidhean Galar Depressive Mòr ann am bailtean eile
- Boston, MA31 sgrùdaidhean
- Atlanta, GA25 sgrùdaidhean
- Philadelphia, PA23 sgrùdaidhean
- Orlando, FL19 sgrùdaidhean
- Miami, FL18 sgrùdaidhean
- Chicago, IL17 sgrùdaidhean
- Tampa, FL17 sgrùdaidhean
- San Diego, CA16 sgrùdaidhean
- Houston, TX16 sgrùdaidhean
- Little Rock, AR14 sgrùdaidhean
- Austin, TX13 sgrùdaidhean
- Las Vegas, NV13 sgrùdaidhean
Sgrùdaidhean eile ann an New York City
- Aillse a' bhroilleach136 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag121 sgrùdaidhean
- Aillse (gach seòrsa)109 sgrùdaidhean
- Aillse Prostata103 sgrùdaidhean
- Ailse metastatach93 sgrùdaidhean
- Aillse colorectal78 sgrùdaidhean
- Cancer Ovarian69 sgrùdaidhean
- Ailseachadh nan Sgamhan60 sgrùdaidhean
- Myeloma iomaill60 sgrùdaidhean
- Cancer Pancreatic60 sgrùdaidhean
- Ailse Endometrial52 sgrùdaidhean
- Leukemia myeloid geur51 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.